Actively Recruiting
Study of MAR002 in Healthy Men
Led by Marea Therapeutics · Updated on 2026-01-12
45
Participants Needed
1
Research Sites
46 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
CONDITIONS
Official Title
Study of MAR002 in Healthy Men
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willingness to provide written informed consent
- Age 18 to 40 years
- Weight between 55 and 95 kilograms
- Body mass index (BMI) between 18 and 30 kg/m2
- Healthy men
You will not qualify if you...
- History of hypersensitivity to monoclonal antibodies or the study drug
- Participation in any other investigational drug study
- History of cancer
- Recent acute illness
- Positive test for HIV, hepatitis B, or hepatitis C
- History of substance abuse or nicotine use
- Recent blood donation
- History of pituitary disorder
- Any condition that prevents compliance with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Marea Site
Tempe, Arizona, United States, 85283
Actively Recruiting
Research Team
A
Andrew Lane
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
TREATMENT
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here